Safety, Tolerability and Pharmacokinetics of CMS121, a Drug Candidate for Alzheimer's Disease, in Healthy Subjects
Clinical trial NCT05318040 · COMPLETED
Trial details
- NCT number
- NCT05318040
- Sponsor
- Virogenics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2022-12-17
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.